| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/25/2012 | CN101341160B Process for production of water-soluble azole prodrug |
| 01/25/2012 | CN101119991B Salt of proline derivative, solvate thereof, and production method thereof |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101793 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101635 Use of glutamate antagonists which is a NMDA receptor antagonist ( ifenprodil, memantine) to reduce or control retinal pigment epithelium and/or glial migration and the subsequent development of proliferative vitreoretinopathy ( vision defect ) |
| 01/24/2012 | US8101599 Pharmaceutical composition containing anti-hypertensive agents |
| 01/24/2012 | US8101211 Controlling moisture, elasticity of skin; using plant extracts; antiinflammatory agents; antiallergens |
| 01/24/2012 | US8101188 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/24/2012 | US8101176 Compositions and methods related to TIM-3, a TH1-specific cell surface molecule |
| 01/24/2012 | CA2677313C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases |
| 01/24/2012 | CA2656216C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/24/2012 | CA2579810C Stable pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide |
| 01/24/2012 | CA2520436C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/24/2012 | CA2493644C Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/24/2012 | CA2439428C Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/24/2012 | CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 01/24/2012 | CA2406168C Polyamide nucleic acid derivatives, agents and methods for producing same |
| 01/24/2012 | CA2394327C Substituted piperazine and piperidine calcium channel blockers |
| 01/24/2012 | CA2387542C Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2269204C Anti-erbb2 antibodies |
| 01/24/2012 | CA2221730C Use of angiotensin ii type 2 receptor agonists in tissue repair |
| 01/24/2012 | CA2221318C High affinity oligonucleotide ligands to growth factors |
| 01/19/2012 | WO2012009678A1 Therapeutically active compositions and their method of use |
| 01/19/2012 | WO2012009646A1 Methods of treating fragile x syndrome, down's syndrome, autism and related disorders |
| 01/19/2012 | WO2012008565A1 Imidazoline derivatives |
| 01/19/2012 | WO2012008564A1 Nitrogenated aromatic heterocyclic ring derivative |
| 01/19/2012 | WO2012008563A1 Nitrogenated aromatic heterocyclic ring derivative |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008528A1 Pyrazole compound |
| 01/19/2012 | WO2012008508A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008507A1 Therapeutic agent for cancer |
| 01/19/2012 | WO2012008478A1 P2x4 receptor antagonist |
| 01/19/2012 | WO2012008474A1 Fructose absorption inhibitor |
| 01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | US20120016489 Textured bone block implants |
| 01/19/2012 | US20120016467 Polymer-based, sustained release drug delivery system |
| 01/19/2012 | US20120016035 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/19/2012 | US20120016023 Combination of Selected Opioids with Muscarine Antagonists for Treating Urinary Incontinence |
| 01/19/2012 | US20120016015 Aldehyde conjugated flavonoid preparations |
| 01/19/2012 | US20120015976 Autotaxin inhibitors |
| 01/19/2012 | US20120015971 Ophthalmic composition comprising ascomycin |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015945 Use of cb1 antagonists and/or inverse agonists for the preparation of drugs that increase motor neuron excitability |
| 01/19/2012 | US20120015911 Method and compositions for treating amyloid-related diseases |
| 01/19/2012 | US20120015868 Metastin derivatives and use thereof |
| 01/19/2012 | US20120015042 Rna sequence-specific mediators of rna interference |
| 01/19/2012 | US20120015024 Methods for treating tweak-related conditions |
| 01/19/2012 | US20120015020 Biodegradable drug or other active delivery system |
| 01/19/2012 | US20120015006 Flowable collagen material for dural closure |
| 01/19/2012 | US20120014968 Stabilized formulations containing anti-ngf antibodies |
| 01/19/2012 | US20120014961 Antibodies that inhibit tslp activity |
| 01/19/2012 | US20120014955 Antagonists of IL-6 to raise albumin and/or lower CRP |
| 01/19/2012 | US20120014936 Methods and compositions for cns delivery of heparan n-sulfatase |
| 01/19/2012 | US20120014876 Antagonistic peptides for frizzled-1 and frizzled-2 |
| 01/19/2012 | US20120014872 Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers |
| 01/19/2012 | US20120014868 Methods to diagnose degenerative disc disease |
| 01/19/2012 | CA2807354A1 P2x4 receptor antagonist |
| 01/19/2012 | CA2805669A1 Therapeutically active compositions and their methods of use |
| 01/19/2012 | CA2805219A1 Pyrazole compound |
| 01/18/2012 | EP2407786A1 Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer |
| 01/18/2012 | EP2407556A1 Method for determining sensitivity to irinotecan and use thereof |
| 01/18/2012 | EP2407453A1 PGD2 receptor antagonist |
| 01/18/2012 | EP2407175A1 Agents with angiogenic and wound healing activity |
| 01/18/2012 | EP2406248A1 Novel isoindolin-1-one derivative |
| 01/18/2012 | EP2405924A1 Plasma-adapted full electrolyte solution |
| 01/18/2012 | EP2405919A2 Treating chronic fatigue syndrome and prolonged qt interval |
| 01/18/2012 | EP2405906A2 Method of use of vitamin k as energy enhancer in diverse disease states |
| 01/18/2012 | EP1992618B1 Polycyclic cinnamide derivative |
| 01/18/2012 | EP1808446B1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/18/2012 | EP1726310B1 Drug for cancer therapy |
| 01/18/2012 | EP1637539B1 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 01/18/2012 | EP1486213B1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |
| 01/18/2012 | EP1390075B1 Chemotherapeutic induction of egr-1 promoter activity in gene therapy |
| 01/18/2012 | CN102325905A Method for determining sensitivity to irinotecan and use thereof |
| 01/18/2012 | CN102321626A Means for inhibiting the expression of protein kinase 3 |
| 01/18/2012 | CN102321573A Tangential flow filtration devices and methods for stem cell enrichment |
| 01/18/2012 | CN102319421A Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 01/18/2012 | CN101524493B Multifunctional Chinese medicine honeyed pill |
| 01/17/2012 | US8097611 Sulfonyl-derivatives as novel or histone deacetylase |
| 01/17/2012 | US8097598 Porcine CTLA-4 for xenograft-specific immunosuppression |
| 01/17/2012 | US8097593 Lipid A and other carbohydrate ligand analogs |
| 01/17/2012 | US8097589 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 01/17/2012 | US8097458 Micro-carrier culture system for rapid expansion of human embryonic stem cells |
| 01/17/2012 | US8097279 Chewable soft capsule |
| 01/17/2012 | US8097254 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 01/17/2012 | CA2517390C Chroman-derived anti-androgens for treatment of androgen-mediated disorders |
| 01/17/2012 | CA2500873C Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 01/17/2012 | CA2485852C Agent for binding a plurality of c-reactive protein and their use in the treatment and prevention of tissue damage |
| 01/17/2012 | CA2484640C Vitamin-mitomycin conjugates |
| 01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
| 01/17/2012 | CA2470255C N4-acylcytosine nucleosides for treatment of viral infections |
| 01/17/2012 | CA2451244C Purine derivatives as a2b adenosine receptor antagonists |
| 01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
| 01/17/2012 | CA2429998C Intraocular implants for preventing transplant rejection in the eye |
| 01/17/2012 | CA2414542C Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells using electric current |